Solventum Corp | SOLV - Sales Revenues

Stock Price
74.26
Daily Change
-0.16 -0.22%
Monthly
7.81%
Yearly
0.20%
Q2 Forecast
72.77

Solventum Corp reported $2.01B in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Abbott USD 11.16B 300M Mar/2026
Align Technology USD 1.04B 10M Mar/2026
Baxter International USD 2.7B 270M Mar/2026
Becton, Dickinson and Co. USD 4.7B 600M Mar/2026
Cencora USD 78.4B 7.53B Jun/2026
Dexcom USD 1.19B 70M Mar/2026
Insulet USD 761.7M 22.1M Mar/2026
Solventum Corp USD 2.01B 20M Mar/2026
West Pharmaceutical Services USD 844.9M 39.9M Mar/2026
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026